CopyFind
Uzpruvo
medicine 📍 EU

Uzpruvo

Analogs of Uzpruvo

Find cheaper analogs and generic equivalents for Uzpruvo.

Ingredients

Active Ingredient: ustekinumab


Product Overview

About Uzpruvo

Uzpruvo is a prescription medicine that should be given under the supervision of a doctor who has experience in diagnosing and treating the diseases that Uzpruvo is used for.

What it is used for

Uzpruvo is used for plaque psoriasis and psoriatic arthritis, and Crohn’s disease.

How it is used

For plaque psoriasis and psoriatic arthritis, Uzpruvo is injected under the skin using a pre-filled syringe. The first injection is followed by a further injection 4 weeks later, and then an injection every 12 weeks. In Crohn’s disease, treatment must be started as an infusion (drip) into a vein over at least 1 hour. Eight weeks after the infusion, Uzpruvo can then be given as an injection under the skin and patients can continue with Uzpruvo every 8 or 12 weeks depending on how well the treatment is working.

How it works

The active substance in Uzpruvo, ustekinumab, is a monoclonal antibody that attaches to 2 messenger molecules in the immune system called interleukin 12 and interleukin 23. By blocking their activity, ustekinumab reduces the activity of the immune system and the symptoms of the disease.

Active substance: ustekinumab

Source: EMA EPAR

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.

Similar Products & Analogs

OTULFI

Active: USTEKINUMAB

Match: 100% Compare →
Usgena

Active: ustekinumab

Match: 100% Compare →
Usymro

Active: ustekinumab

Match: 100% Compare →
STELARA

Active: USTEKINUMAB

Match: 100% Compare →
FINLIUS

Active: USTEKINUMAB

Match: 100% Compare →
JAMTEKI

Active: USTEKINUMAB

Match: 100% Compare →
WEZLANA

Active: USTEKINUMAB

Match: 100% Compare →
Wezenla

Active: ustekinumab

Match: 100% Compare →
Usrenty

Active: ustekinumab

Match: 100% Compare →
Absimky

Active: ustekinumab

Match: 100% Compare →
Eksunbi

Active: ustekinumab

Match: 100% Compare →
STEQEYMA

Active: USTEKINUMAB

Match: 100% Compare →